Japanese CTO PCI Expert Registry
- Conditions
- Chronic Total Occlusion of Coronary Artery
- Registration Number
- NCT01889459
- Lead Sponsor
- Kurashiki Central Hospital
- Brief Summary
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 19000
Patients eligible for PCI
Patients who underwent PCI for CTO lesions that contain the following:
- Thrombolysis in myocardial infarction trial (TIMI) 0
- The occlusive period more than 3 months or unknown
- The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Patients ineligible for PCI judged in clinical practice
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method successful revascularization without any major adverse cardiocerebral events (MACCE) at early follow-up and MACCE during the 5-year follow-up within the first 1 month (plus 1 month) after PCI and during the 5-year follow-up early and late results on major adverse cardiocerebral events (MACCE): all-cause death, coronary artery bypass grafting, re-PCI (target lesion revascularization/target vessel revascularization), admission for heart failure, myocardial infarction, admission for unstable angina, cerebrovascular disease, stent thrombosis in 19000 patients in and outside Japan
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kurashiki Central Hospital
🇯🇵Kurashiki, Japan